321 related articles for article (PubMed ID: 9672068)
1. Distinct promoters induce APOBEC-1 expression in rat liver and intestine.
Greeve J; Axelos D; Welker S; Schipper M; Greten H
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1079-92. PubMed ID: 9672068
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of the rat apobec-1 gene: a comparative analysis of gene structure and promoter usage in rat and mouse.
Hirano K; Min J; Funahashi T; Davidson NO
J Lipid Res; 1997 Jun; 38(6):1103-19. PubMed ID: 9215539
[TBL] [Abstract][Full Text] [Related]
3. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.
Nakamuta M; Oka K; Krushkal J; Kobayashi K; Yamamoto M; Li WH; Chan L
J Biol Chem; 1995 Jun; 270(22):13042-56. PubMed ID: 7768898
[TBL] [Abstract][Full Text] [Related]
4. Two distinct TATA-less promoters direct tissue-specific expression of the rat apo-B editing catalytic polypeptide 1 gene.
Qian X; Balestra ME; Innerarity TL
J Biol Chem; 1997 Jul; 272(29):18060-70. PubMed ID: 9218436
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression and increased CpG dinucleotide methylation of the rat APOBEC-1 promoter in transgenic rabbits.
Apostel F; Dammann R; Pfeifer GP; Greeve J
Biochim Biophys Acta; 2002 Sep; 1577(3):384-94. PubMed ID: 12359328
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
[TBL] [Abstract][Full Text] [Related]
8. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.
Morrison JR; Pászty C; Stevens ME; Hughes SD; Forte T; Scott J; Rubin EM
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7154-9. PubMed ID: 8692961
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
Sowden MP; Eagleton MJ; Smith HC
Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins.
Greeve J; Altkemper I; Dieterich JH; Greten H; Windler E
J Lipid Res; 1993 Aug; 34(8):1367-83. PubMed ID: 8409768
[TBL] [Abstract][Full Text] [Related]
12. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
13. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
Siddiqui JF; Van Mater D; Sowden MP; Smith HC
Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
Mehta A; Kinter MT; Sherman NE; Driscoll DM
Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.
Yamanaka S; Balestra ME; Ferrell LD; Fan J; Arnold KS; Taylor S; Taylor JM; Innerarity TL
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8483-7. PubMed ID: 7667315
[TBL] [Abstract][Full Text] [Related]
16. C-->U editing of apolipoprotein B mRNA in marsupials: identification and characterisation of APOBEC-1 from the American opossum Monodelphus domestica.
Fujino T; Navaratnam N; Jarmuz A; von Haeseler A; Scott J
Nucleic Acids Res; 1999 Jul; 27(13):2662-71. PubMed ID: 10373583
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
MacGinnitie AJ; Anant S; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
[TBL] [Abstract][Full Text] [Related]
18. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
Mehta A; Driscoll DM
RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
[TBL] [Abstract][Full Text] [Related]
19. Apobec-1 and apolipoprotein B mRNA editing.
Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
[TBL] [Abstract][Full Text] [Related]
20. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.
Yamanaka S; Poksay KS; Driscoll DM; Innerarity TL
J Biol Chem; 1996 May; 271(19):11506-10. PubMed ID: 8626710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
